NEW YORK, NY
Flatiron Health today announced 21 abstracts accepted for presentation at the 2019 American Society for Clinical Oncology (ASCO) Annual Meeting, which will be held May 31 – June 4 in Chicago. The research, spanning multiple tumor types and areas of study, utilized Flatiron’s high-quality, real-world oncology datasets.
The research to be presented includes collaborations between Flatiron and the U.S. Food and Drug Administration, National Cancer Institute, Fight Colorectal Cancer, Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Tesaro, Roche/Genentech and Foundation Medicine.
The presentation schedule and links to abstracts can be found below. Learn more about our abstracts by clicking on each link or see our recent blog post for more information.
Plenary Session
- Presenting Author: Amy Davidoff, PhD (Yale Cancer Center)
- Date/Time: June 2 — 1:45 – 2:00pm
- Abstract: #LBA1
- Location: Hall B1
- Track: Special Sessions
Poster Discussion
Genomic Characterization of Lung Tumors and Metastatic Sites in Advanced NSCLC
- First Author: Melinda Willard (Eli Lilly and Company)
- Date/Time: June 2 — 4:30 – 6:00pm
- Abstract: #2014
- Poster: #203
- Location: S404
- Track: Central Nervous System Tumors
Poster Sessions (Location: Hall A)
Organ Dysfunction and Clinical Outcomes in Patients Treated with Immune Checkpoint Inhibitors
- First Author: Qi Li, PhD (U.S. Food and Drug Administration)
- Date/Time: June 1 — 8:00 – 11:00am
- Abstract: #2569
- Poster: #213
- Track: Developmental Immunotherapy and Tumor Immunobiology
Tumor Mutational Burden and PD-L1 Expression as Predictors of Response to Immunotherapy in NSCLC
- First Author: Emily Castellanos, MD, MPH (Flatiron Health)
- Date/Time: June 1 — 8:00 – 11:00am
- Abstract: #2630
- Poster: #274
- Track: Developmental Immunotherapy and Tumor Immunobiology
Impact of Oncology Care Model Reporting Requirements on Quality of Care
- First Author: Emily Castellanos, MD, MPH (Flatiron Health)
- Date/Time: June 1 — 1:15 – 4:15pm
- Abstract: #6620
- Poster: #311
- Track: Health Services Research, Clinical Informatics, and Quality of Care
Using Real-World Cohorts to Assess the Generalizability and Relevance of Randomized Clinical Trials
- First Author: Caroline Bennette, MPH, PhD (Flatiron Health)
- Date/Time: June 1 — 1:15 – 4:15pm
- Abstract: #6540
- Poster: #231
- Track: Health Services Research, Clinical Informatics, and Quality of Care
- First Author: Neal Shore, FACS, MD
- Date/Time: June 1 — 1:15 – 4:15pm
- Abstract: #5026
- Poster: #138
- Track: Health Services Research, Clinical Informatics, and Quality of Care
Recurrence of Ovarian Cancer in BRCAwt Patients without Maintenance Therapy: Real-World Evidence
- First Author: Melinda Louie-Gao, PhD (TESARO, Inc.)
- Date/Time: June 1 — 1:15 – 4:15pm
- Abstract: #5547
- Poster: #370
- Track: Gynecologic Cancer
- First Author: Shannon Neville Westin, MD (MD Anderson Cancer Center)
- Date/Time: June 1 — 1:15 – 4:15pm
- Abstract: #5547
- Poster: #371
- Track: Gynecologic Cancer
- First Author: Emily Nash Smyth, PharmD (Eli Lilly and Company)
- Date/Time: June 2 — 8:00 – 11:00am
- Abstract: #2035
- Poster: #224
- Track: Central Nervous System Tumors
- First Author: Celine Mascaux, MD, PhD (Aix-Marseille University)
- Date/Time: June 2 — 8:00 – 11:00am
- Abstract: #9076
- Poster: #399
- Track: Lung Cancer—Non-Small Cell Metastatic
- First Author: Cynthia Huang Bartlett, MD (Pfizer)
- Date/Time: June 2 — 8:00 – 11:00am
- Abstract: #1055
- Poster: #136
- Track: Breast Cancer—Metastatic
- First Author: Michael Leapman, MD (Yale School of Medicine)
- Date/Time: June 2 — 8:00 – 11:00am
- Abstract: #9059
- Poster: #382
- Track: Lung Cancer—Non-Small Cell Metastatic
- First Author: Gregory J. Riely, MD, PhD (Memorial Sloan Kettering Cancer Center)
- Memorial Sloan Kettering Cancer Center
- Date/Time: June 2 — 8:00 – 11:00am
- Abstract: #9062
- Poster: #385
- Track: Lung Cancer—Non-Small Cell Metastatic
- First Author: Robert Charles Doebele, MD, PhD (University of Colorado)
- Date/Time: June 2 — 8:00 – 11:00am
- Abstract: #9070
- Poster: #393
- Track: Lung Cancer—Non-Small Cell Metastatic
- First Author: Sam Whipple, MSPH (Genentech)
- Date/Time: June 2 — 8:00 – 11:00am
- Abstract #9113
- Poster #436
- Track: Lung Cancer—Non-Small Cell Metastatic
Chromosome 1 Abnormalities and Clinical Outcomes in Multiple Myeloma in the Era of Novel Agents
- First Author: Smith Giri, MBBS (Yale School of Medicine)
- Date/Time: June 3 — 8:00 – 11:00am
- Abstract: #8044
- Poster: #370
- Track: Hematologic Malignancies—Plasma Cell Dyscrasia
Utilization and reach of the Fight Colorectal Cancer Late Stage MSS CRC Clinical Trial Finder
- First Author: Reese Garcia, MPH (Fight Colorectal Cancer)
- Date/Time: June 3 — 8:00 – 11:00am
- Abstract: #3561
- Poster: #53
- Track: Gastrointestinal (Colorectal) Cancer
- First Author: Kimmie McLaurin, MS (AstraZeneca)
- Date/Time: June 3 — 1:15 – 4:15pm
- Abstract: #1563
- Poster: #57
- Track: Cancer Prevention, Hereditary Genetics, and Epidemiology
Burden of Thrombocytopenia in Adult Cancer Patients Receiving Chemotherapy
- First Author: Gerald Soff, MD (Memorial Sloan Kettering Cancer Center)
- Date/Time: June 3 — 1:15 – 4:15pm
- Abstract: #1555
- Poster: #49
- Track: Cancer Prevention, Hereditary Genetics, and Epidemiology
- First Author: Alicia Morgans, MD, MPH (Northwestern University)
- Date/Time: June 3 — 1:15 – 4:15pm
- Abstract: #4526
- Poster: #352
- Track: Genitourinary (Nonprostate) Cancer
About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.